The role of platelets in ischemic stroke

Neurology

Volumn 51, Issue 3 SUPPL., 1998, Pages

  Del Zoppo, Gregory J ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; DIPYRIDAMOLE;

ANTICOAGULANT THERAPY; ARTICLE; BRAIN HEMORRHAGE; BRAIN PROTECTION; CEREBROVASCULAR ACCIDENT; DOSE RESPONSE; HEMOSTASIS; HUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; THROMBOCYTE AGGREGATION; THROMBOGENESIS;

EID: 0031657877     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/wnl.51.3_suppl_3.s9     Document Type: Article

References (32)

1. Denny-Brown D. Recurrent cerebrovascular episodes. Arch Neurol 1960;2:194-210.
2. Russell RWR. Observations on the retinal blood vessels in monocular blindness. Lancet 1961;2:1422-1428.
3. Hollenhorst RW. Vascular status of patients who have cholesterol emboli in the retina. Am J Ophthalmol 1966;61:1159-1165.
4. Barnett HJ. The pathophysiology of transient cerebral ischemic attacks. Med Clin North Am 1979;63:649-679.
5. Barnett HJ. Delayed cerebral ischemic episodes distal to occlusion of major cerebral arteries. Neurology 1978;28:769-774.
6. del Zoppo GJ, Poeck K, Pessin MS, et al. Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke. Ann Neurol 1992;32:78-86.
7. Fieschi C, Argentino C, Lenzi GL, Sacchetti ML, Toni D, Bozzao L. Clinical and instrumental evaluation of patients with ischemic stroke within the first six hours. J Neurol Sci 1989; 91:311-321.
8. del Zoppo GJ, Higashida RT, Furlan AJ, Pessin MS, Rowley HA, Gent M. PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. Stroke 1998;29:4-11.
9. de Gaetano G, ed. 1997 State of the Art: XVIth Congress of the International Society on Thrombosis and Haemostasis. Thromb Haemost 1997;78:1-784.
10. 3 and platelet function. Thromb Haemost 1997;78:96-100.
11. Nurden P. Bidirectional trafficking of membrane glycoproteins following platelet activation in suspension. Thromb Haemost 1997;78:1305-1315.
12. Iwamoto T, Kubo H, Takasaki M. Platelet activation in the cerebral circulation in different subtypes of ischemic stroke and Binswanger's disease. Stroke 1995;26:52-56.
13. Konstantopoulos K, Grotta JC, Sills C, Wu KK, Hellums JD. Shear-induced platelet aggregation in normal subjects and stroke patients. Thromb Haemost 1995;74:1329-1334.
14. del Zoppo GJ, Copeland BR, Harker LA, et al. Experimental acute thrombotic stroke in baboons. Stroke 1986;17:1254-1265.
15. Okada Y, Copeland BR, Mori E, Tung M-M, Thomas WS, del Zoppo GJ. P-selectin and intercellular adhesion molecule-1 expression after focal brain ischemia and reperfusion. Stroke 1994;25:202-211.
16. del Zoppo GJ, Schmid-Schönbein GW, Mori E, Copeland BR, Chang C-M. Polymorphonuclear leukocytes occlude capillaries following middle cerebral artery occlusion and reperfusion in baboons. Stroke 1991;22:1276-1283.
17. Okada Y, Copeland BR, Fitridge R, Koziol JA, del Zoppo GJ. Fibrin contributes to microvascular obstructions and parenchymal changes during early focal cerebral ischemia and reperfusion. Stroke 1994;25:1847-1853.
18. Thomas WS, Mori E, Copeland BR, Yu J-Q, Morrissey JH, del Zoppo GJ. Tissue factor contributes to microvascular defects after focal cerebral ischemia. Stroke 1993;24:847-853.
19. 1. Biochem Biophys Res Commun 1995;206:570-576.
20. 1-integrin by the snake venom metalloproteinase jararhagin. Biochem J 1996;320(Pt 2):635-641.
21. Hoogendijk EM, Jenkins CS, van Wijk EM, Vos J, ten Cate JW. Spontaneous platelet aggregation in cerebrovascular disease: II. further characterisation of the platelet defect. Thromb Haemost 1979;41:512-522.
22. Cella G, Zahavi J, de Haas HA, Kakkar W. β-Thromboglobulin, platelet production time, and platelet function in vascular disease. Br J Haematol 1979;43:127-136.
23. Fisher M, Levine PH, Fullerton AL, et al. Marker proteins of platelet activation in patients with cerebrovascular disease. Arch Neurol 1982;39:692-695.
24. de Boer AC, Turpie AG, Butt RW, Duke RJ, Bloch RF, Genton E. Plasma β-thromboglobulin and serum fragment E in acute partial stroke. Br J Haematol 1982;50:327-334.
25. Taomoto K, Asada M, Kanazawa Y, Matsumoto S. Usefulness of the measurement of plasma β-thromboglobulin (β-TG) in cerebrovascular disease. Stroke 1983;14:518-524.
26. Lane DA, Wolff S, Ireland H, Gawel M, Foadi M. Activation of coagulation and fibrinolytic systems following stroke. Br J Haematol 1983;53:655-658.
27. Shah AB, Beamer N, Coull BM. Enhanced in vivo platelet activation in subtypes of ischemic stroke. Stroke 1985;16:643-647.
28. Landi G, D'Angelo A, Boccardi E, et al. Hypercoagulability in acute stroke: prognostic significance. Neurology 1987;37: 1667-1671.
29. Fisher M, Francis R. Altered coagulation in cerebral ischemia: platelet, thrombin, and plasmin activity. Arch Neurol 1990;47: 1075-1079.
30. Feinberg WM. Coagulation. In: Caplan LR, ed. Brain ischemia: basic concepts and clinical relevance. London: Springer-Verlag, 1995:85-96.
31. Couch JR, Hassanein RS. Platelet aggregation, stroke, and transient ischemic attack in middle-aged and elderly patients. Neurology 1976;26:888-895.
32. Dougherty JH Jr, Levy DE, Weksler BB. Platelet activation in acute cerebral ischemia: serial measurements of platelet function in cerebrovascular disease. Lancet 1977;1:821-824.